Patent details

EP2593475 Title: ANTI-ADDL MONOCLONAL ANTIBODY AND USES THEREOF

Basic Information

Publication number:
EP2593475
PCT Application Number:
PCT/US/2011/043866
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP118074574
PCT Publication Number:
WO/2012/009442
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
ANTI-ADDL MONOCLONAL ANTIBODY AND USES THEREOF
French Title of Invention:
ANTICORPS MONOCLONAL ANTI-ADDL ET SES UTILISATIONS
German Title of Invention:
MONOKLONALER ANTIKÖRPER GEGEN ADDL UND ANWENDUNGEN DAVON
SPC Number:

Dates

Filing date:
13/07/2011
Grant date:
02/03/2016
EP Publication Date:
02/03/2016
PCT Publication Date:
19/01/2012
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
22/05/2013
EP B1 Publication Date:
02/03/2016
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
13/07/2016
Expiration date:
13/07/2031
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
13/07/2011
 
 

Name:
Merck Sharp & Dohme Corp.
Address:
126 East Lincoln Avenue, Rahway, NJ 07065-0907, United States (US)

Inventor

1

Name:
GASPAR Renee C.
Address:
United States (US)

2

Name:
McCAMPBELL Alexander
Address:
United States (US)

3

Name:
XU Min
Address:
United States (US)

4

Name:
SHUGHRUE Paul J.
Address:
United States (US)

5

Name:
ZHAO Wei-Qin
Address:
United States (US)

6

Name:
WANG Weirong
Address:
United States (US)

7

Name:
ZHANG Ningyan
Address:
United States (US)

8

Name:
WANG Fubao
Address:
United States (US)

Priority

Priority Number:
364210 P
Priority Date:
14/07/2010
Priority Country:
United States (US)

Classification

Main IPC Class:
C07K 16/18;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages